Botulinum toxin versus placebo injection for plantar fasciitis at 6 and 12 month follow-up .
Treatment of Plantar Fasciitis With Botulinum Toxin: A Randomized, Controlled Study
Foot Ankle Int. 2017 Jan;38(1):1-750 patients with plantar fasciitis were randomized to injection of the flexor digitorum brevis with either botulinum toxin or placebo. Patients were followed up for patient-reported function and pain at 6 and 12 months. Results demonstrated significantly higher scores on the Foot and Ankle Ability Measure in the botulinum toxin group compared to the placebo group at 6 and 12 months, as well as significantly lower visual analog pain scores at 6 and 12 months.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
